Alisha Holtzhausen

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Dendritic Cells

Top Venues

Cancer immunology research

Science immunology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Eden Y Zewdie, George M Edwards, Debra M Hunter, Henry Shelton Earp, Alisha Holtzhausen
MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming. Cancer immunology research (2024)
Eden Y Zewdie, George M Edwards, Debra M Hunter, Henry Shelton Earp, Alisha Holtzhausen
MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming. Cancer immunology research 12 (9) (2024)
Michael P Plebanek, Yue Xue, Y-Van Nguyen, Nicholas C DeVito, Xueying Wang, Alisha Holtzhausen, Georgia M Beasley, Balamayooran Theivanthiran, Brent A Hanks
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Science immunology 9 (95) (2024)
Michael P Plebanek, Yue Xue, Y-Van Nguyen, Nicholas C DeVito, Xueying Wang, Alisha Holtzhausen, Georgia M Beasley, Balamayooran Theivanthiran, Brent A Hanks
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Science immunology 9 (95) (2024)
Eden Y Zewdie, George M Edwards, Debra M Hunter, Henry Shelton Earp, Alisha Holtzhausen
MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming. Cancer immunology research (2024)
Balamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, Y-Van Nguyen, Linda Cao, Michelle Ferreira, Alisha Holtzhausen, Rami Nayef Al-Rohil, April K S Salama, Georgia M Beasley, Michael P Plebanek, Nicholas C DeVito, Brent A Hanks
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy. Science translational medicine 14 (672) (2022)
Balamayooran Theivanthiran, Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael Plebanek, Nicholas C DeVito, Brent A Hanks
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers 13 (19) (2021)
Alisha Holtzhausen, William Harris, Eric Ubil, Debra M Hunter, Jichen Zhao, Yuewei Zhang, Dehui Zhang, Qingyang Liu, Xiaodong Wang, Douglas K Graham, Stephen V Frye, Henry Shelton Earp
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma. Cancer immunology research 7 (10) (2019)
Yao Jiang, Yanqiong Zhang, Janet Y Leung, Cheng Fan, Konstantin I Popov, Siyuan Su, Jiayi Qian, Xiaodong Wang, Alisha Holtzhausen, Eric Ubil, Yang Xiang, Ian Davis, Nikolay V Dokholyan, Gang Wu, Charles M Perou, William Y Kim, H Shelton Earp, Pengda Liu
MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression. Nature communications 10 (1) (2019)
Fei Zhao, Kathy Evans, Christine Xiao, Nicholas DeVito, Balamayooran Theivanthiran, Alisha Holtzhausen, Peter J Siska, Gerard C Blobe, Brent A Hanks
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma. Cancer immunology research 6 (12) (2018)